Navigation Links
CHPA Statement on Statewide Indiana Consumer Poll
Date:3/4/2013

WASHINGTON, March 4, 2013 /PRNewswire/ -- The Consumer Healthcare Products Association (CHPA) released the following statement today on a recent poll of Indiana voters conducted by The Polling Company and supported by CHPA. The poll, which surveyed 607 Hoosiers on February 4-6th, found that a 65 percent majority of Hoosiers opposed changing state law to require a doctor's prescription for cold and allergy medicines containing the decongestant pseudoephedrine (PSE).  The poll also found that 84 percent of respondents report they use PSE-containing medicines to treat common symptoms.

"The new Indiana survey is very important because in recent months, well-intentioned lawmakers have proposed legislation that would make it difficult for law-abiding Hoosiers to access the nonprescription medicines they know and trust," said Carlos Gutierrez , senior director of state government affairs for CHPA. "Clearly these proposals do not have the support of Indiana voters, many of whom sufferer from frequent cold and allergy symptoms. While we support efforts to combat the illegal sales of pseudoephedrine, lawmakers should advance solutions that target criminals, not honest citizens. To that end, CHPA is doing everything possible to help Senator Carlin Yoder garner support for his commonsense anti-meth bill, SB 496. Senator Yoder's bill would enhance the state's electronic PSE tracking system, implement stiffer penalties for meth-related crime, and apply sensible PSE purchasing limits."

Key findings from the poll:  

  • 84% of Hoosiers report they rely on the over-the-counter medicines containing pseudoephedrine that would be impacted by changing the law to require a doctor's prescription.
  • A 65%-majority of Hoosiers opposed changing the law to require a doctor's prescription for the purchase of cold and allergy medicines containing pseudoephedrine.  This total included 52% that STRONGLY opposed new rules for pseudoephedrine medicines that are currently sold over-the-counter.  In contrast, 29% of voters supported the new law.
  • By a 59%-35% spread, voters were more likely to agree "it is not worth inconveniencing, or possibly criminalizing law-abiding Hoosiers who benefit from over-the-counter cold or allergy medicines" than that "the benefits would outweigh the inconvenience or cost of a new law."
  • A 65%-majority were "less supportive" toward changing the law knowing that it could increase costs to taxpayers, as uninsured Hoosiers would have to visit emergency rooms to get prescriptions for these medicines.

CHPA is the 132-year-old-trade association representing U.S. manufacturers and distributors of over-the-counter medicines and dietary supplements.

chpa-info.org


'/>"/>
SOURCE Consumer Healthcare Products Association
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sonitus Medical Announces Affirmative Update Regarding Bone Conduction Oral Appliances in American Academy of Otolaryngology-Head and Neck Surgery Policy Statement on Implantable Hearing Devices
2. Amgen Statement On Government Budget Analysis For Oral-Only Treatments For Dialysis Patients
3. Statement from Ralph G. Neas, President and CEO, Generic Pharmaceutical Association, on the Front Page New York Times Story Regarding the Pre-emptive Strikes of Amgen/Genentech to Restrict Access to Affordable and Safe Biosimilars
4. Emmaus Life Sciences Issues Statement in Response to Announcement by AFH Holding & Advisory
5. Hill-Rom Reports Fiscal First Quarter Results; Updates 2013 Financial Outlook For R&D Tax Credit Reinstatement
6. CVS Caremark Statement and Response to CMS Action
7. World Renowned Scientist, Dr. Rongxiang Xu Speaks Out About Nobel Assembly Statement Claiming They Have Not Heard Of Him
8. STATEMENT OF CHAIRMAN AND CEO GEORGE BARRETT FORTUNE 21 CARDINAL HEALTH REGARDING FISCAL CLIFF
9. PCMA Statement on Essential Health Benefits Proposed Rule
10. Emmaus CEO Yutaka Niihara, M.D., Issues Statement In Connection with Status of Companys Phase III FDA Sickle Cell Treatment Trials
11. Academy of Managed Care Pharmacy (AMCP) Statement on Outcome of 2012 Presidential Election
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... April 19, 2017 Global Surgical Drainage Device ... tubes used to remove excess liquid and air. The ... urine, bile or lymph. Surgical drains are used in ... as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. ... to prevent accumulation of fluid e.g. blood or pus. ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group ... it is developing at Conejo Spectrum Business Park ... to Atara Biotherapeutics, Inc. , a biopharmaceutical ... and life-threatening diseases that have been underserved by ... T-cell therapies for cancer, autoimmune and infectious disease. ...
Breaking Medicine Technology:
(Date:4/25/2017)... Richmond, BC (PRWEB) , ... April 25, 2017 , ... ... patients from Richmond, BC, who live with dental fear and require sedation to receive ... anxiety at ease during various procedures, from hygienic cleanings to oral surgery, at ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... they rely on contracted partners to help with process innovation in drug formulation ... drug formulation experience along with state-of-the-art analytical equipment in support of their development ...
(Date:4/25/2017)... MN (PRWEB) , ... April 25, 2017 , ... Buyers ... and recreational users to dispensaries and head shops –can’t help but be heartened by ... for the tell-tale cannabis odor aptly described as “skunk smell.” At last they ...
(Date:4/25/2017)... ... 25, 2017 , ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley ... in Writing, set to publish in summer 2017. , Dr. Bobrow, MD, FACEP, ... Arizona College of Medicine. He also serves as Medical Director for the Bureau of ...
(Date:4/25/2017)... ... April 25, 2017 , ... Amendia, Inc., designer, developer, and ... partnership with and platinum sponsorship of Global Spine Outreach (“GSO”), a charitable organization ... of complex spine deformity cases, particularly in children. , GSO’s focus is to ...
Breaking Medicine News(10 mins):